227 related articles for article (PubMed ID: 31715358)
21. Curcumin-carboxymethyl chitosan (CNC) conjugate and CNC/LHR mixed polymeric micelles as new approaches to improve the oral absorption of P-gp substrate drugs.
Ni J; Tian F; Dahmani FZ; Yang H; Yue D; He S; Zhou J; Yao J
Drug Deliv; 2016 Nov; 23(9):3424-3435. PubMed ID: 27198856
[TBL] [Abstract][Full Text] [Related]
22. pH-Responsive polymeric micelles based on amphiphilic chitosan derivatives: Effect of hydrophobic cores on oral meloxicam delivery.
Woraphatphadung T; Sajomsang W; Gonil P; Treetong A; Akkaramongkolporn P; Ngawhirunpat T; Opanasopit P
Int J Pharm; 2016 Jan; 497(1-2):150-60. PubMed ID: 26657271
[TBL] [Abstract][Full Text] [Related]
23. Tissue distribution and pharmacokinetics evaluation of DOMC-FA micelles for intravenous delivery of PTX.
Wang F; Zhang D; Zhang Q; Guo S; Zheng D; Hao L; Guo H; Li C
J Drug Target; 2013 Feb; 21(2):137-45. PubMed ID: 23046502
[TBL] [Abstract][Full Text] [Related]
24. [Solubilizing and sustained-releasing abilities and safety preliminary evaluation for paclitaxel based on N-octyl-O, N-carboxymethyl chitosan polymeric micelles].
Huo MR; Zhang Y; Zhou JP; Lü L; Liu H; Liu FJ
Yao Xue Xue Bao; 2008 Aug; 43(8):855-61. PubMed ID: 18956780
[TBL] [Abstract][Full Text] [Related]
25. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
[TBL] [Abstract][Full Text] [Related]
26. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells.
Roger E; Lagarce F; Garcion E; Benoit JP
Eur J Pharm Sci; 2010 Aug; 40(5):422-9. PubMed ID: 20438839
[TBL] [Abstract][Full Text] [Related]
27. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
Jin X; Mo R; Ding Y; Zheng W; Zhang C
Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
[TBL] [Abstract][Full Text] [Related]
28. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
29. Rational design of hybrid nanomicelles integrating mucosal penetration and P-glycoprotein inhibition for efficient oral delivery of paclitaxel.
Lian H; He Z; Meng Z
Colloids Surf B Biointerfaces; 2017 Jul; 155():429-439. PubMed ID: 28463810
[TBL] [Abstract][Full Text] [Related]
30. PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation.
Qu G; Yao Z; Zhang C; Wu X; Ping Q
Eur J Pharm Sci; 2009 May; 37(2):98-105. PubMed ID: 19429416
[TBL] [Abstract][Full Text] [Related]
31. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.
Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F
Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782
[TBL] [Abstract][Full Text] [Related]
32. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
[TBL] [Abstract][Full Text] [Related]
33. The enhancing effect of N-acetylcysteine modified hyaluronic acid-octadecylamine micelles on the oral absorption of paclitaxel.
Zhang M; Asghar S; Jin X; Hu Z; Ping Q; Chen Z; Shao F; Xiao Y
Int J Biol Macromol; 2019 Oct; 138():636-647. PubMed ID: 31330211
[TBL] [Abstract][Full Text] [Related]
34. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel.
Emami J; Rezazadeh M; Hasanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Rostami M; Davies N
Int J Biol Macromol; 2015 Sep; 80():29-40. PubMed ID: 26093319
[TBL] [Abstract][Full Text] [Related]
35. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
[TBL] [Abstract][Full Text] [Related]
36. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation.
Dahmani FZ; Yang H; Zhou J; Yao J; Zhang T; Zhang Q
Eur J Pharm Sci; 2012 Aug; 47(1):179-89. PubMed ID: 22683386
[TBL] [Abstract][Full Text] [Related]
37. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
[TBL] [Abstract][Full Text] [Related]
38. Potential of amphiphilic graft copolymer α-tocopherol succinate-g-carboxymethyl chitosan in modulating the permeability and anticancer efficacy of tamoxifen.
Jena SK; Samal SK; Kaur S; Chand M; Sangamwar AT
Eur J Pharm Sci; 2017 Apr; 101():149-159. PubMed ID: 28214545
[TBL] [Abstract][Full Text] [Related]
39. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.
Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC
J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497
[TBL] [Abstract][Full Text] [Related]
40. In vivo pharmacokinetics, biodistribution and antitumor effect of paclitaxel-loaded micelles based on α-tocopherol succinate-modified chitosan.
Liang N; Sun S; Hong J; Tian J; Fang L; Cui F
Drug Deliv; 2016 Oct; 23(8):2651-2660. PubMed ID: 26165423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]